Global Vaccine Adjuvants Market Insights, Forecast to 2029

Global Vaccine Adjuvants Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2018-2029
2.2 Global Vaccine Adjuvants Revenue by Region
2.2.1 Global Vaccine Adjuvants Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vaccine Adjuvants Revenue by Region (2018-2023)
2.2.3 Global Vaccine Adjuvants Revenue by Region (2024-2029)
2.2.4 Global Vaccine Adjuvants Revenue Market Share by Region (2018-2029)
2.3 Global Vaccine Adjuvants Sales Estimates and Forecasts 2018-2029
2.4 Global Vaccine Adjuvants Sales by Region
2.4.1 Global Vaccine Adjuvants Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vaccine Adjuvants Sales by Region (2018-2023)
2.4.3 Global Vaccine Adjuvants Sales by Region (2024-2029)
2.4.4 Global Vaccine Adjuvants Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaccine Adjuvants Sales by Manufacturers
3.1.1 Global Vaccine Adjuvants Sales by Manufacturers (2018-2023)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Adjuvants in 2022
3.2 Global Vaccine Adjuvants Revenue by Manufacturers
3.2.1 Global Vaccine Adjuvants Revenue by Manufacturers (2018-2023)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2022
3.3 Global Key Players of Vaccine Adjuvants, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Vaccine Adjuvants Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaccine Adjuvants, Product Offered and Application
3.8 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccine Adjuvants Sales by Type
4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2018-2023)
4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2024-2029)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2018-2029)
4.2 Global Vaccine Adjuvants Revenue by Type
4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2018-2023)
4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine Adjuvants Price by Type
4.3.1 Global Vaccine Adjuvants Price by Type (2018-2023)
4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vaccine Adjuvants Sales by Application
5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2018-2023)
5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2024-2029)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2018-2029)
5.2 Global Vaccine Adjuvants Revenue by Application
5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2018-2023)
5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine Adjuvants Price by Application
5.3.1 Global Vaccine Adjuvants Price by Application (2018-2023)
5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vaccine Adjuvants Market Size by Type
6.1.1 US & Canada Vaccine Adjuvants Sales by Type (2018-2029)
6.1.2 US & Canada Vaccine Adjuvants Revenue by Type (2018-2029)
6.2 US & Canada Vaccine Adjuvants Market Size by Application
6.2.1 US & Canada Vaccine Adjuvants Sales by Application (2018-2029)
6.2.2 US & Canada Vaccine Adjuvants Revenue by Application (2018-2029)
6.3 US & Canada Vaccine Adjuvants Market Size by Country
6.3.1 US & Canada Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vaccine Adjuvants Sales by Country (2018-2029)
6.3.3 US & Canada Vaccine Adjuvants Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaccine Adjuvants Market Size by Type
7.1.1 Europe Vaccine Adjuvants Sales by Type (2018-2029)
7.1.2 Europe Vaccine Adjuvants Revenue by Type (2018-2029)
7.2 Europe Vaccine Adjuvants Market Size by Application
7.2.1 Europe Vaccine Adjuvants Sales by Application (2018-2029)
7.2.2 Europe Vaccine Adjuvants Revenue by Application (2018-2029)
7.3 Europe Vaccine Adjuvants Market Size by Country
7.3.1 Europe Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vaccine Adjuvants Sales by Country (2018-2029)
7.3.3 Europe Vaccine Adjuvants Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaccine Adjuvants Market Size
8.1.1 China Vaccine Adjuvants Sales (2018-2029)
8.1.2 China Vaccine Adjuvants Revenue (2018-2029)
8.2 China Vaccine Adjuvants Market Size by Application
8.2.1 China Vaccine Adjuvants Sales by Application (2018-2029)
8.2.2 China Vaccine Adjuvants Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vaccine Adjuvants Market Size by Type
9.1.1 Asia Vaccine Adjuvants Sales by Type (2018-2029)
9.1.2 Asia Vaccine Adjuvants Revenue by Type (2018-2029)
9.2 Asia Vaccine Adjuvants Market Size by Application
9.2.1 Asia Vaccine Adjuvants Sales by Application (2018-2029)
9.2.2 Asia Vaccine Adjuvants Revenue by Application (2018-2029)
9.3 Asia Vaccine Adjuvants Sales by Region
9.3.1 Asia Vaccine Adjuvants Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vaccine Adjuvants Revenue by Region (2018-2029)
9.3.3 Asia Vaccine Adjuvants Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaccine Adjuvants Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaccine Adjuvants Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vaccine Adjuvants Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaccine Adjuvants Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vaccine Adjuvants Sales by Country
10.3.1 Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vaccine Adjuvants Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 CSL Limited
11.2.1 CSL Limited Company Information
11.2.2 CSL Limited Overview
11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Limited Recent Developments
11.3 Croda
11.3.1 Croda Company Information
11.3.2 Croda Overview
11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Croda Recent Developments
11.4 SEPPIC
11.4.1 SEPPIC Company Information
11.4.2 SEPPIC Overview
11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SEPPIC Recent Developments
11.5 Novavax
11.5.1 Novavax Company Information
11.5.2 Novavax Overview
11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novavax Recent Developments
11.6 SPI Pharma
11.6.1 SPI Pharma Company Information
11.6.2 SPI Pharma Overview
11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SPI Pharma Recent Developments
11.7 Phibro
11.7.1 Phibro Company Information
11.7.2 Phibro Overview
11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Phibro Recent Developments
11.8 SDA BIO
11.8.1 SDA BIO Company Information
11.8.2 SDA BIO Overview
11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SDA BIO Recent Developments
11.9 Invivogen
11.9.1 Invivogen Company Information
11.9.2 Invivogen Overview
11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Invivogen Recent Developments
11.10 Tj Kaiwei
11.10.1 Tj Kaiwei Company Information
11.10.2 Tj Kaiwei Overview
11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tj Kaiwei Recent Developments
11.11 OZ Biosciences
11.11.1 OZ Biosciences Company Information
11.11.2 OZ Biosciences Overview
11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 OZ Biosciences Recent Developments
11.12 Brenntag Biosector
11.12.1 Brenntag Biosector Company Information
11.12.2 Brenntag Biosector Overview
11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Brenntag Biosector Recent Developments
11.13 MVP Laboratories
11.13.1 MVP Laboratories Company Information
11.13.2 MVP Laboratories Overview
11.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MVP Laboratories Recent Developments
11.14 Zhuoyue
11.14.1 Zhuoyue Company Information
11.14.2 Zhuoyue Overview
11.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhuoyue Recent Developments
11.15 Aphios
11.15.1 Aphios Company Information
11.15.2 Aphios Overview
11.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Aphios Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccine Adjuvants Industry Chain Analysis
12.2 Vaccine Adjuvants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine Adjuvants Production Mode & Process
12.4 Vaccine Adjuvants Sales and Marketing
12.4.1 Vaccine Adjuvants Sales Channels
12.4.2 Vaccine Adjuvants Distributors
12.5 Vaccine Adjuvants Customers
13 Market Dynamics
13.1 Vaccine Adjuvants Industry Trends
13.2 Vaccine Adjuvants Market Drivers
13.3 Vaccine Adjuvants Market Challenges
13.4 Vaccine Adjuvants Market Restraints
14 Key Findings in The Global Vaccine Adjuvants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Aluminum Adjuvant
Table 3. Major Manufacturers of Emulsions Adjuvant
Table 4. Major Manufacturers of Others
Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Vaccine Adjuvants Revenue Market Share by Region (2018-2023)
Table 10. Global Vaccine Adjuvants Revenue Market Share by Region (2024-2029)
Table 11. Global Vaccine Adjuvants Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 13. Global Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 14. Global Vaccine Adjuvants Sales Market Share by Region (2018-2023)
Table 15. Global Vaccine Adjuvants Sales Market Share by Region (2024-2029)
Table 16. Global Vaccine Adjuvants Sales by Manufacturers (2018-2023) & (MT)
Table 17. Global Vaccine Adjuvants Sales Share by Manufacturers (2018-2023)
Table 18. Global Vaccine Adjuvants Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Vaccine Adjuvants Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Vaccine Adjuvants, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Vaccine Adjuvants Price by Manufacturers 2018-2023 (USD/Kg)
Table 22. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)
Table 24. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Vaccine Adjuvants, Product Offered and Application
Table 26. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 29. Global Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 30. Global Vaccine Adjuvants Sales Share by Type (2018-2023)
Table 31. Global Vaccine Adjuvants Sales Share by Type (2024-2029)
Table 32. Global Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Vaccine Adjuvants Revenue Share by Type (2018-2023)
Table 35. Global Vaccine Adjuvants Revenue Share by Type (2024-2029)
Table 36. Vaccine Adjuvants Price by Type (2018-2023) & (USD/Kg)
Table 37. Global Vaccine Adjuvants Price Forecast by Type (2024-2029) & (USD/Kg)
Table 38. Global Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 39. Global Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 40. Global Vaccine Adjuvants Sales Share by Application (2018-2023)
Table 41. Global Vaccine Adjuvants Sales Share by Application (2024-2029)
Table 42. Global Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Vaccine Adjuvants Revenue Share by Application (2018-2023)
Table 45. Global Vaccine Adjuvants Revenue Share by Application (2024-2029)
Table 46. Vaccine Adjuvants Price by Application (2018-2023) & (USD/Kg)
Table 47. Global Vaccine Adjuvants Price Forecast by Application (2024-2029) & (USD/Kg)
Table 48. US & Canada Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 49. US & Canada Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 50. US & Canada Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 53. US & Canada Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 54. US & Canada Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Vaccine Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 60. US & Canada Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 61. Europe Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 62. Europe Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 63. Europe Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 66. Europe Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 67. Europe Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Vaccine Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 73. Europe Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 74. China Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 75. China Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 76. China Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 79. China Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 80. China Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 83. Asia Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 84. Asia Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 87. Asia Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 88. Asia Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Vaccine Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 94. Asia Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 95. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 96. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 97. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 100. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 101. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Vaccine Adjuvants Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 107. Middle East, Africa and Latin America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 108. GSK Company Information
Table 109. GSK Description and Major Businesses
Table 110. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 111. GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GSK Recent Developments
Table 113. CSL Limited Company Information
Table 114. CSL Limited Description and Major Businesses
Table 115. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 116. CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. CSL Limited Recent Developments
Table 118. Croda Company Information
Table 119. Croda Description and Major Businesses
Table 120. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 121. Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Croda Recent Developments
Table 123. SEPPIC Company Information
Table 124. SEPPIC Description and Major Businesses
Table 125. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 126. SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. SEPPIC Recent Developments
Table 128. Novavax Company Information
Table 129. Novavax Description and Major Businesses
Table 130. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 131. Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Novavax Recent Developments
Table 133. SPI Pharma Company Information
Table 134. SPI Pharma Description and Major Businesses
Table 135. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 136. SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. SPI Pharma Recent Developments
Table 138. Phibro Company Information
Table 139. Phibro Description and Major Businesses
Table 140. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 141. Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Phibro Recent Developments
Table 143. SDA BIO Company Information
Table 144. SDA BIO Description and Major Businesses
Table 145. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 146. SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. SDA BIO Recent Developments
Table 148. Invivogen Company Information
Table 149. Invivogen Description and Major Businesses
Table 150. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 151. Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Invivogen Recent Developments
Table 153. Tj Kaiwei Company Information
Table 154. Tj Kaiwei Description and Major Businesses
Table 155. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 156. Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Tj Kaiwei Recent Developments
Table 158. OZ Biosciences Company Information
Table 159. OZ Biosciences Description and Major Businesses
Table 160. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 161. OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. OZ Biosciences Recent Developments
Table 163. Brenntag Biosector Company Information
Table 164. Brenntag Biosector Description and Major Businesses
Table 165. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 166. Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Brenntag Biosector Recent Developments
Table 168. MVP Laboratories Company Information
Table 169. MVP Laboratories Description and Major Businesses
Table 170. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 171. MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. MVP Laboratories Recent Developments
Table 173. Zhuoyue Company Information
Table 174. Zhuoyue Description and Major Businesses
Table 175. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 176. Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Zhuoyue Recent Developments
Table 178. Aphios Company Information
Table 179. Aphios Description and Major Businesses
Table 180. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 181. Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Aphios Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Vaccine Adjuvants Distributors List
Table 186. Vaccine Adjuvants Customers List
Table 187. Vaccine Adjuvants Market Trends
Table 188. Vaccine Adjuvants Market Drivers
Table 189. Vaccine Adjuvants Market Challenges
Table 190. Vaccine Adjuvants Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaccine Adjuvants Market Share by Type in 2022 & 2029
Figure 4. Aluminum Adjuvant Product Picture
Figure 5. Emulsions Adjuvant Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Vaccine Adjuvants Market Share by Application in 2022 & 2029
Figure 9. Human Vaccine
Figure 10. Veterinary Vaccine
Figure 11. Vaccine Adjuvants Report Years Considered
Figure 12. Global Vaccine Adjuvants Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vaccine Adjuvants Revenue 2018-2029 (US$ Million)
Figure 14. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Vaccine Adjuvants Revenue Market Share by Region (2018-2029)
Figure 16. Global Vaccine Adjuvants Sales 2018-2029 ((MT)
Figure 17. Global Vaccine Adjuvants Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Vaccine Adjuvants Sales YoY (2018-2029) & (MT)
Figure 19. US & Canada Vaccine Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Vaccine Adjuvants Sales YoY (2018-2029) & (MT)
Figure 21. Europe Vaccine Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Vaccine Adjuvants Sales YoY (2018-2029) & (MT)
Figure 23. China Vaccine Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Vaccine Adjuvants Sales YoY (2018-2029) & (MT)
Figure 25. Asia (excluding China) Vaccine Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Vaccine Adjuvants Sales YoY (2018-2029) & (MT)
Figure 27. Middle East, Africa and Latin America Vaccine Adjuvants Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Vaccine Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Vaccine Adjuvants in the World: Market Share by Vaccine Adjuvants Revenue in 2022
Figure 30. Global Vaccine Adjuvants Market Share by

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs